Specialty Laboratories & Henry
Mayo Newhall Memorial Hospital Present:
A Seven Gene Signature Identifies the Risk of Developing Cirrhosis in Chronic Hepatitis C Patients .
Now that the program is over, participants are be able to describe
new criteria for determining which chronic hepatitis C patients
are at risk for progression to liver cirrhosis. The presentation
discussed the gene discovery process and development of
the Cirrhosis Risk Score which stratifies hepatitis C patients
into low or high risk cohorts for progression to cirrhosis.
 |
Robert
Kisabeth, MD
National Esoteric Medical Director, Specialty Laboratories |
|
Hongjin
Huang, PhD
Associate Director Liver Disease Program, Celera Diagnostics |
|
 Henry
Mayo Newhall Memorial Hospital (HMNMH) is accredited by the
Institute of Medical Quality/California Medical Association
(IMQ/CMA) to provide continuing medical education for physicians.
HMNMH takes responsibility for the content, quality, and scientific
integrity of this CME activity. HMNMH designates this educational
activity for a maximum of 1 AMA PRA Category 1 credit™.
Physicians should claim credit commensurate with the extent
of their participation in the activity. This credit may also
be applied to the CMA Certification in Continuing Medical
Education. |
|
| CME Library |
Read about and evaluate previous CME Conferences:
|
Click below to request a HCV Liver Fibrosis GenotypR™ packet.
|
